TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME AFTER RECONSTRUCTIVE INTERVENTION ON THE AORTA.
Purpose - to improve the results of reconstructive interventions on the aorta by improving methods for treating respiratory distress syndrome. The study included 15 men and 4 women, the median age was 48 ±4 years. In all patients, on the basis of a clinical and instrumental study and in accordance with the AECC criteria, acute lung injury syndrome (ALIS) was diagnosed, and in fourteen patients (73,7%), the severity corresponded to acute respiratory distress syndrome (ARDS). The diagnosis of ARDS was established on the basis of generally accepted criteria: acute onset; the presence of bilateral infiltrates on the chest radiograph; a decrease in the PaO2/FiO2 index of less than 300 mm hg. art.; the absence of signs of left ventricular failure. To maintain normal oxygen delivery values, we ensured a hemoglobin level of at least 100 g / l. In cases of heart failure (HF), inotropic support was performed. Basic therapy provided for the maintenance of adequate oxygen delivery, for this a hemoglobin level of at least 100 g/l was provided, and in the development of HF, inotropic support was provided. When analyzing the timing of administration and the effectiveness of surfactant therapy, there is a tendency to a more significant increase in the PaO2/FiO2 index with the early introduction of surfactant. When using surfactant, mortality in cases of ARDS was 25,0-40,0%, and the time of respiratory support in patients was 136±57 hours. Endobronchial administration of a surfactant agent is a pathogenically reasonable pharmacological method of intensive therapy of acute respiratory distress syndrome in the postoperative period following aortic interventions. Administration of surfactant therapy leads to a significant reduction in the terms of recovery of oxygenation, respiratory therapy and the stay of patients in the ICU.